Elevated levels of aminotransferases, such as ALT, or the incidental discovery of hepatic fat through imaging often lead to a diagnosis of Non-Alcoholic Fatty Liver Disease (NAFLD), and its more severe form, Non-Alcoholic Steatohepatitis (NASH), in both humans and animals [142]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatohepatitis.